Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 05, 2022 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Stevia Market Worth $1.11 Billion by 2028 - Exclusive Report by Meticulous Research®
January 04, 2022 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
London, Jan. 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled “Stevia Market by Type (Extract [Powder, Liquid], Leaves); Nature (Conventional, Organic); Components (Reb...
Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
2021 Outlook on Pediatrics Partnering Deals - In-depth Review of Deals Entered into by the Top 25 Most Active Dealmakers
January 04, 2022 05:23 ET
|
Research and Markets
Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Pediatrics Partnering 2010-2021: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global...
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 07:00 ET
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
EnBiotix, Inc. Closes $11M Pre-Merger Financing
December 29, 2021 02:30 ET
|
EnBiotix, Inc.
BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) -- EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible...
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
December 23, 2021 17:16 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan
December 22, 2021 09:12 ET
|
Dyadic International, Inc.
JUPITER, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
2021 Outlook on the Orphan Diseases Partnering Global Deals Market - Featuring Oxford BioMedica, Edmond Pharma and Abbvie Among Others
December 22, 2021 04:23 ET
|
Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Orphan Diseases Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
Sanofi: Information concerning the total number of voting rights and shares - NOVEMBER 2021
December 21, 2021 15:52 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...